Cyclosporin A therapy for interstitial pneumonitis associated with rheumatic disease

Modern Rheumatology

Volumn 12, Issue 4, 2002, Pages 305-310

  Tokano, Yoshiaki ^a   Ogasawara, Hitoshi ^a   Ando, Souichiro ^a   Fujii, Taketo ^a   Kaneko, Hiroshi ^a   Tamura, Naoto ^a   Yano, Tetsuro ^a   Hirokawa, Kaoru ^a   Fukazawa, Toru ^a   Murashima, Atsuko ^a   Kobayashi, Shigeto ^a   Sekigawa, Iwao ^a   Takasaki, Yoshinari ^a   Iida, Noboru ^a   Hashimoto, Hiroshi ^a  

^a JUNTENDO UNIVERSITY   (Japan)

Author keywords

Cyclosporin A; Interstitial pneumonitis (IP); Polymyositis dermatomyositis (PM DM); Systemic sclerosis (SSc)

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; LACTATE DEHYDROGENASE; METHOTREXATE; OXYGEN; PREDNISOLONE; STEROID;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTERIAL OXYGEN TENSION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DERMATOMYOSITIS; DISEASE ASSOCIATION; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG PULSE THERAPY; DRUG RESPONSE; FEMALE; HUMAN; HYPOXIA; INFECTION; INTERSTITIAL PNEUMONIA; KIDNEY DYSFUNCTION; LACTATE DEHYDROGENASE BLOOD LEVEL; LEUKOPENIA; LIVER DYSFUNCTION; LUNG TOXICITY; MALE; MIXED CONNECTIVE TISSUE DISEASE; PILOT STUDY; POLYMYOSITIS; PRIORITY JOURNAL; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; SYMPTOMATOLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; THORAX RADIOGRAPHY;

EID: 19244365938     PISSN: 14397595     EISSN: None     Source Type: Journal    
DOI: 10.1007/s101650200054     Document Type: Article

References (26)

1. Borel JF, Kis ZL, Beveridge T. The history of the discovery and development of cyclosporine (Sandimmune). In: Merluzzi VJ, Adams J, editors. The search for anti-inflammatory drugs. Boston: Birkhausr; 1995. p. 27-63.
2. Witcup SM, Salvo EC Jr, Nussenblatt RB. Combined cyclosporine and corticosteroid therapy for sight-threatening uveitis in Behçet's disease. Am J Ophthalmol 1994;118:39-45.
3. Pacor ML, Biasi D, Lunardi C, Cortina P, Caramaschi P, Girelli D, et al. Cyclosporine in Behçet's disease: results in 16 patients after 24 months of therapy. Clin Rheumatol 1994;13:224-7.
4. Christophers E, Mrowietz U, Henneicke HH, Farber L, Welzel D. Cyclosporine in psoriasis. The German Multicenter Study. J Am Acad Dermatol 1992;26:86-90.
5. Pei Y, Scholey JW, Katz A, Schachter R, Murphy GF, Cattran D. Chronic nephrotoxicity in psoriatic patients treated with low-dose cyclosporine. Am J Kidney Dis 1994;23:528-36.
6. Mahrle G, Schultze HJ, Farbar L, Weidinger G, Steigleder GK. Low-dose short-term cyclosporine versus etretinate in psoriasis: improvement of skin, nail, and joint involvement. J Am Acad Dermatol 1995;32:78-88.
7. Tugwell P, Bombardier C, Gent M, Bennett KJ, Bensen WG, Carette S. Low dose cyclosporine versus placebo in patients with rheumatoid arthritis. Lancet 1990;335:1051-5.
8. Tokuda M, Kurata N, Mizoguchi A, Inoh M, Seto K, Kinashi M, et al. Effect of low-dose cyclosporin A on systemic lupus erythematosus disease activity. Arthritis Rheum 1994;37:551-8.
9. Ippoliti G, Miori L, Negri M, Rovati B, Lorenzutti F, Zerbinati N, et al. Cyclosporine in treatment of progressive systemic sclerosis: clinical and immunologic findings. Transplant Proc 1994;26:3117-8.
10. Gruhn WB, Diaz-Buxo JA. Cyclosporine treatment of steroid resistant interstitial pneumonitis associated with dermatomyositis/ polymyositis. J Rheumatol 1987;14:1045-7.
11. Lambie PB, Quismorio FP Jr. Interstitial lung disease and cryoglobulinemia in polymyositis. J Rheumatol 1991;18:468-9.
12. Pugh MT, Collins MA, Rai A, Hollinrake K, Coppock JS. A case of adult dermatomyositis treated with cyclosporin A. Br J Rheumatol 1992;31:855-60.
13. Lueck CJ, Trend P, Swash M. Cyclosporine in the management of polymyositis and dermatomyositis. J Neurol Neurosurg Psychiatry 1991;54:1007-8.
14. Javier A, Joaquin T, Bonifacio A, Jose LV. Successful use of cyclosporine for the treatment of aggressive pulmonary fibrosis in a patient with rheumatoid arthritis. Arthritis Rheum 1990;33:1594-6.
15. Ando S, Kobayashi S, Yamanaka K, Hashimoto H. Successful combination therapy with cyclosporine and steroid for two patients who had interstitial pneumonitis associated with polymyositis (in Japanese). Riumachi 1995;35:95-9.
16. Puttick MPE, Klinkhoff AV, Chalmers A, Ostrow DN. Treatment of progressive rheumatoid interstitial lung disease with cylosporine. J Rheumatol 1995;22:2163-65.
17. Borg G. Subjective effort and physical activities. Scand J Rehabil Med 1978;6:108-13.
18. Kalovidouris AE. The role of cell-mediated immunity in polymyositis. Curr Opin Rheumatol 1993;20:77-9.
19. Plotz PH, Rider LG, Targoff IN, Raben N, O'Hanlon TP, Miller FW. Myositis: immunologic contributions to understanding cause, pathogenesis, and therapy. Ann Intern Med 1995;122:715-24.
20. Kanai Y, Tokano Y, Tsuda H, Hashimoto H, Hirose S. HLA-DP positive T cells in patients with polymyositis/dermatomyositis. J Rheumatol 1993;20:77-9.
21. Tokano Y, Morimoto S, Kaneko H, Amano H, Nozawa K, Takasaki Y, et al. Levels of IL-12 in the sera of patients with systemic lupus erythematosus (SLE) - relation to Th1-and Th2-derived cytokines. Clin Exp Immunol 1999;116:169-73.
22. Murashima A, Sekigawa I, Takasaki Y, Hashimoto H. Cyclosporine treatment of advanced interstitial pneumonitis associated with systemic sclerosis. Jpn J Rheumatol 1999;9:95-9.
23. Fudman EJ, Schnitzer TJ. Dermatomyositis without creatine kinase elevation. A poor prognostic sign. Am J Med 1986;80:329-32.
24. Saeki T, Suzuki T, Watanabe T, Saito Y, Ito S, Honma T, et al. Prognosis of interstitial pneumonitis (IP) in polymyositis (PM)/ dermatomyositis (in Japanese). Riumachi 1994;34:16-21.
25. Nawata Y, Kurasawa K, Takabayashi K, Miike S, Watanabe N, Hiraguri M, et al. Corticosteroid resistant interstitial pneumonitis in dermatomyositis/polymyositis: prediction and treatment with cyclosporine. J Rheumatol 1999;26:1527-33.
26. Ogasawara H, Murashima A, Kaneko H, Hishikawa T, Tokano Y, Sekigawa I, et al. Effect of low-dose cyclosporine treatment on interstitial pneumonitis associated with Sjögren's syndrome. Br J Rheumatol 1998;37:348-9.